Federico Quaini

11PUBLICATIONS
67CO-AUTHORS
AutoimmunityPredictive and prognostic markersMolecular targetsGene and molecular therapyImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 26, 2026
Targeting PI3K/AKT/mTOR Pathway Exerts Inhibitory Effects on Endothelial Cells from Generalized Lymphatic Anomaly.

|Sep 26, 2026
A Comparative Assessment of the Antifibrotic Effect of Nintedanib Administered via a Medicated Diet or Oral Gavage in a Rat Model of Bleomycin-Induced Pulmonary Fibrosis.

|Jul 10, 2026
PYGO2 is overexpressed in multiple myeloma patients with 1q21 amplification, driving plasma cell proliferation and cell cycle progression.

|May 19, 2026
Inhibition of the atypical kinase WNK1 as a therapeutic strategy in TAL-related T-cell acute lymphoblastic leukemia.

|Mar 23, 2026
Transcriptomic analysis reveals lipid metabolism and macrophage involvement associated with nintedanib treatment in a rat bleomycin model.

Martina Bonatti, Vanessa Pitozzi, Paola Caruso

|Jan 10, 2026
In Vivo Target Engagement Assessment of Nintedanib in a Double-Hit Bleomycin Lung Fibrosis Rat Model.

Vanessa Pitozzi, Paola Lorenza Caruso, Silvia Pontis

Pageof 2

Frequent Collaborators

7 joint publications

Bruno Lorusso

6 joint publications

Costanza Anna Maria Lagrasta

4 joint publications

Gregorio Monica

3 joint publications

Marcello Trevisani